Clinical Trial Update: A Phase Ⅲ Clinical Study of MIL62 in Primary Membranous Nephropathy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating MIL62 for primary membranous nephropathy is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• MIL62

Snippet

Sponsor: Beijing Mabworks Biotech Co., Ltd. | Conditions: Primary Membranous Nephropathy | Phase 3 | Status: ACTIVE_NOT_RECRUITING